Targeted vaccination and the speed of SARS-CoV-2 adaptation

S Gandon, S Lion - Proceedings of the National Academy of …, 2022 - National Acad Sciences
… pros and cons of dose-sparing strategies. Because delaying the second dose increases the
… However, vaccine supply shortages have sparked a debate about the optimal distribution of …

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments.

EH Baker, D Gnjidic, CMJ Kirkpatrick… - Br J Clin …, 2021 - openaccess.sgul.ac.uk
… i Define the optimal drug dose(s) and frequency to achieve unbound concentrations in plasma
and tissue to maximise antiviral and/or disease suppressing activity. For antivirals, this will …

Current pharmacological treatments for SARS-COV-2: A narrative review

G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
… do not allow the identification of an optimal dose to guarantee the safety and efficacy of
chloroquine. Further results from ongoing studies will be needed to outline the optimal dose. …

Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: report of the randomized, double-blind, and placebo-controlled …

Y Zhang, G Zeng, H Pan, C Li, B Kan, Y Hu, H Mao… - medrxiv, 2020 - medrxiv.org
… safety of a SARS-CoV-2 inactivated vaccine (CoronaVac). METHODS We conducted a
randomized, double-blind, placebo-controlled trial to evaluate the optimal dose, immunogenicity …

Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec …

DM Skowronski, S Setayeshgar, Y Febriani, M Ouakki… - MedRxiv, 2021 - medrxiv.org
… A 7-8-week interval between doses improved VE and may be optimal in … dose SARS-CoV-2
VE against infection and hospitalization, including with mixed vaccines and extended dosing

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

DT Skelly, AC Harding, J Gilbert-Jaramillo… - Nature …, 2021 - nature.com
… from individuals receiving two doses of the Pfizer vaccine showed a non-significant increase
in binding to SARS-CoV-2 spike and RBD compared to those receiving single dose and a …

… and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose …

PA Goepfert, B Fu, AL Chabanon… - The Lancet Infectious …, 2021 - thelancet.com
… the optimal antigen formulation and dose. … dose levels administered in a 0·5 mL vaccine
dose in this study were 1·3 μg (low dose) and 2·6 μg (high dose) of functional SARS-CoV-2 preS …

A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine

HM Moutsopoulos - Journal of Autoimmunity, 2021 - Elsevier
… treatments seem to compromise optimal antibody responses following SARS-CoV-vaccination
(… individuals after the first vaccine dose developed antibodies against SARS-CoV-2 virus, …

[HTML][HTML] The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 “doublethink” effect

A Manenti, E Molesti, M Maggetti, A Torelli… - Journal of Virological …, 2021 - Elsevier
… The aim of the present preliminary study was to carry out SARS-CoV-2 wild type MN assay
in order to investigate which optimal tissue culture infective dose 50 (TCID 50 ) infective dose

Molnupiravir—a novel oral anti-SARS-CoV-2 agent

CC Lee, CC Hsieh, WC Ko - Antibiotics, 2021 - mdpi.com
… Focusing on adults with early symptomatic COVID-19, the optimal dose and safety of
molnupiravir were evaluated through a multicenter, multistage, open-label, phase-Ib/IIa randomized …